DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

Amicus Therapeutics, Inc. (NASDAQ: FOLD)

17.20 0.81 (4.94%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

FOLD $17.20 4.94%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $16.47
Previous Close $16.39
Daily Range $16.30 - $17.25
52-Week Range $3.92 - $17.42
Market Cap $1.7B
P/E Ratio -17.62
Dividend (Yield) $0.00 (0.0%)
Volume 3,041,102
Average Daily Volume 2,359,976
Current FY EPS -$1.05




Drug Makers

Amicus Therapeutics, Inc. (FOLD) Description

A clinical-stage biopharmaceutical company, which focused on the discovery, development and commercialization of novel small molecule, orally-administered drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases. Website:

News & Commentary

3 Tiny Stocks to Buy If Biotech Tumbles

Ophthotech Corp., Portola Pharmaceuticals, and Amicus Therapeutics could be buys if biotech stocks fall.

Can The Uptrend Continue for Amicus Therapeutics (FOLD)? - Tale of the Tape

5 Drugs That Investors May Be Undervaluing

One Foolish investor thinks these five drugs could send shares in these companies higher.

Why Shares in Amicus Therapeutics Shot Higher in June

Amicus Therapeutics shares jumped on news that it had filed for European approval of Galafold, a therapy for Fabry disease.

Mid-Morning Market Update: Markets Gain; Finish Line Beats Q1 Views

Mid-Morning Market Update: Markets Gain; Finish Line Beats Q1 Views

Morning Market Gainers

Keep An Eye On These 10 After-Hours Movers

Best Places to Invest in Biotechnology

One Foolish contributor shares his top large- and small-cap biotech stocks for portfolios.

MKM Looked To The Options Market To Find Its Top 10 M&A Targets

See More FOLD News...

FOLD's Top Competitors

FOLD $17.20 (4.94%)
Current stock: FOLD
AMGN $176.59 (2.85%)
Current stock: AMGN
GILD $117.86 (-0.03%)
Current stock: GILD
BIIB $318.78 (0.56%)
Current stock: BIIB